ReviewViruses2026
Integrating Epidemiology, Immunology, and Host Genetics for Controlling Peste des Petits Ruminants in Goats.
Review in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Peste des petits ruminants (PPR) is a highly contagious transboundary viral disease of sheep and goats that causes major economic losses and livelihood disruption across Africa, the Middle East, and Asia. Goats are often more severely affected than sheep, particularly in endemic smallholder systems, where high turnover, nutritional stress, and limited veterinary infrastructure sustain viral transmission. Despite effective live attenuated vaccines and the ongoing FAO-WOAH Global Eradication Programme, PPR remains widely distributed, indicating that vaccination alone is insufficient without understanding of host, viral, and environmental determinants of disease persistence. This review synthesizes current knowledge on three interrelated pillars of PPR prevention and control in goats: epidemiology, immunology, and host genetics. We summarize the epidemiological drivers of PPR transmission and how these factors shape disease burden in endemic settings. We review the immunobiology of PPR virus (PPRV) infection and vaccination, focusing on innate antiviral sensing, adaptive immune protection, virus-induced immunosuppression, and field determinants of vaccine performance. Finally, we examine the emerging evidence for host genetic resilience to PPR, with emphasis on immunogenomic and transcriptomic findings and the relevance of indigenous breeds such as the Black Bengal goat as genomic resources. Current evidence suggests that genetic resilience to PPR is likely polygenic and remains insufficiently characterized, though genomic and transcriptomic tools offer opportunities to identify markers of reduced susceptibility, milder disease, or improved vaccine response. Sustainable control of PPR in goats will require integrated strategies combining mass vaccination, surveillance, improved husbandry, and host-focused immunogenomic research to strengthen herd resilience and accelerate progress toward global eradication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.